Half of patients who received an experimental pancreatic cancer vaccine developed by Roche and BioNTech in an early-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback